REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Preparations Characterized By Special Physical Form > Implant Or Insert > Ocular > Bioerrodable, Resorbable, Or Dissolving Bioerrodable, Resorbable, Or DissolvingBioerrodable, Resorbable, Or Dissolving patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.05/31/07 - 20070122450 - Treatment of ophthalmic conditions Ophthalmic conditions such as presbyopia, myopia, and astigmatism can be corrected by the use of a molding contact lens in combination with a pharmaceutical composition suitable for delivery to the eye. The molding contact lenses are preferably commercially available and are not specifically designed for orthokeratology. The agents in the ... 05/24/07 - 20070116741 - Contact lenses with mucin affinity A biomedical device surface, such as a contact lens surface, is covalently linked to a cationic copolymer. The copolymer may include monomeric units derived from an ethylenically unsaturated monomer containing a quaternary ammonium moiety and monomeric units derived from an ethylenically unsaturated monomer containing a moiety reactive with complementary reactive ... 05/24/07 - 20070116740 - Contact lenses with mucin affinity A biomedical device, such as a contact lens, has a surface linked to a polymer comprising boronic acid moieties. The boronic acid monomeric units may be derived from an ethylenically unsaturated monomer containing a boronic acid moiety, such as a vinylphenyl boronic acid or a (meth)acrylamido phenyl boronic acid. The ... 05/03/07 - 20070098760 - Method for treating and/or preventing retinal diseases with sustained release corticosteroids The present invention relates to a method for administering a corticosteroid to a posterior segment of an eye. In the method, a sustained release device is implanted to deliver the corticosteroid to the eye. The aqueous corticosteroid concentration remains less than vitreous corticosteroid concentration during release of the corticosteroid from ... 02/08/07 - 20070031473 - Drug delivery system and method A method of introducing a beneficial substance into the body is presented. The method includes the steps of loading biodendrimer with the beneficial substance, and positioning the biodendrimer relative to the body, such that the beneficial substance can be absorbed by the body. ... 12/07/06 - 20060275342 - Polymerizable surfactants and their use as device forming comonomers This invention describes the use of polymerizable surfactants at percent by weight of less than 15% as comonomers in forming ophthalmic devices such as contact lenses, intraocular lenses, corneal implants, etc. ... 09/28/06 - 20060216329 - Drug delivery system and method A method of introducing a beneficial substance into the body is presented. The method includes the steps of loading biodendrimer with the beneficial substance, and positioning the biodendrimer relative to the body, such that the beneficial substance can be absorbed by the body. ... 06/01/06 - 20060115516 - Copolymerizable methine and anthraquinone compounds and articles containing them This invention relates to polymerizable ultraviolet light absorbers and yellow colorants and their use in ophthalmic lenses. In particular, this invention relates to polymerizable ultraviolet light absorbing methine compounds and yellow compounds of the methine and anthraquinone classes that block ultraviolet light and/or violet-blue light transmission through ophthalmic lenses. ... 05/25/06 - 20060110430 - Copolymerizable azo compounds and articles containing them Polymerizable light absorbing azo dyes are disclosed useful as monomers in the formation of devices such as, but not limited to ocular lenses. Specifically, intraocular lenses (IOL) are disclosed wherein one or more of the light absorbing dye is covalently bonded to other structural polymers though ethylene unsaturated groups. The ... 03/30/06 - 20060067981 - Contact lens with improved biocidal activity and related methods and materials The present invention is directed to a contact lens comprising a porous lens material and a disinfectant, including but not limited to domiphen bromide. The disinfectant is typically absorbed into the pores of the lens. The present invention also includes a related process for manufacture, method of use and kit. ... 11/17/05 - 20050255144 - Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases This invention provides articles and methods for drug delivery including a hydrogel containing one or more drugs for the treatment of a posterior segment disease and/or dry eye conditions. Exemplary drugs are anti-angiogenesis compounds for the treatment of macular degeneration. Allowing passive transference of this drug from a dilute solution ... 11/03/05 - 20050244479 - Sustained release intraocular implants and methods for preventing retinal dysfunction Biocompatible intraocular implants include an alpha-2 adrenergic receptor agonist and a polymer associated with the alpha-2 adrenergic receptor agonist to facilitate release of the alpha-2 adrenergic receptor agonist into an eye for an extended period of time. The alpha-2 adrenergic receptor agonist may be associated with a biodegradable polymer matrix, ... 11/03/05 - 20050244478 - Anti-excititoxic sustained release intraocular implants and related methods Biocompatible intraocular implants include an anti-excitotoxic agent and a biodegradable polymer that is effective to facilitate release of the anti-excitotoxic agent into an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is ... ### FreshPatents.com Support |